Table 2.
Periprocedural Details, Discharge Medication, and Ischemia Testing
| Complete Revascularization (n = 150) |
IRA-Only Revascularization (n = 146) |
p Value | |
|---|---|---|---|
| ASA | 141/142 (99.3) | 131/135 (97.0) | 0.16 |
| Plus clopidogrel | 59/144 (41.0) | 54/138 (39.1) | 0.75 |
| Plus ticagrelor | 19/144 (13.2) | 18/135 (13.3) | 0.97 |
| Plus prasugrel | 58/144 (40.3) | 64/138 (46.4) | 0.30 |
| Plus warfarin | 1/147 (0.7) | 2/138 (1.5) | 0.61 |
| GPI | 46/145 (31.7) | 44/139 (31.7) | 0.99 |
| Bivalirudin | 79/139 (56.8) | 65/128 (50.8) | 0.32 |
| TIMI flow grade 0/1 on arrival | 120/147 (81.6) | 118/140 (84.3) | 0.55 |
| Thrombus aspiration catheter used | 93/145 (64.1) | 105/140 (75.0) | 0.047 |
| DES | 141/147 (95.9) | 127/140 (90.7) | 0.08 |
| Stents per patient | 3 (2–4) | 1 (1–2) | <0.0001 |
| Total procedure time, min | 55 (38–74) | 41 (30–55.5) | <0.0001 |
| Total contrast used, ml | 250 (190–330) | 190 (150–250) | <0.0001 |
| Beta-blocker | 137/147 (93.2) | 126/135 (93.3) | 0.96 |
| ACEI/ARB | 142/147 (96.6) | 129/135 (95.6) | 0.65 |
| Statin | 146/146 (100) | 133/135 (98.5) | 0.14 |
| Aldosterone antagonist | 9/147 (6.1) | 8/135 (5.9) | 0.95 |
| Other antianginal agent | 55/147 (37.4) | 49/135 (36.3) | 0.85 |
| Loop diuretic agent | 15/147 (10.2) | 17/135 (12.6) | 0.53 |
Values are n/N (%) or median (interquartile range).
ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; ASA = acetylsalicylic acid; DES = drug-eluting stent(s); GPI = glycoprotein IIb/IIIa inhibitor; IRA = infarct-related artery; TIMI = Thrombolysis In Myocardial Infarction.